tradingkey.logo
tradingkey.logo

Bioventus Inc

BVS
7.460USD
+0.080+1.08%
終値 12/26, 16:00ET15分遅れの株価
499.62M時価総額
47.61直近12ヶ月PER

Bioventus Inc

7.460
+0.080+1.08%

詳細情報 Bioventus Inc 企業名

Bioventus Inc. is a medical device company. The Company’s portfolio of products is grouped into three areas. Its Pain Treatments include the Knee Osteoarthritis (KOA) area, and Peripheral Nerve Stimulation (PNS) area. Its Surgical Solutions include Ultrasonics, which offers precision bone resection for patients with degenerative spine conditions and spinal deformities, and Bone Graft Substitutes (BGS), which includes a range of products that facilitate optimal bone fusion following a surgical procedure. Its Restorative Therapies comprise Fracture Care that provide low-intensity pulse ultrasound to help patients who suffer from bone fractures that do not heal through traditional methods. It offers a diverse portfolio of products to support physicians in relieving pain and addressing musculoskeletal challenges across indications and clinical areas, including knee, hand and upper extremities, foot and ankle, podiatry, trauma, general surgery, spine and neurosurgery.

Bioventus Incの企業情報

企業コードBVS
会社名Bioventus Inc
上場日Feb 11, 2021
最高経営責任者「CEO」Claypoole (Robert E)
従業員数930
証券種類Ordinary Share
決算期末Feb 11
本社所在地4721 Emperor Boulevard, Suite 100
都市DURHAM
証券取引所NASDAQ OMX - NASDAQ BASIC
United States of America
郵便番号27703
電話番号19194746700
ウェブサイトhttps://www.bioventus.com/
企業コードBVS
上場日Feb 11, 2021
最高経営責任者「CEO」Claypoole (Robert E)

Bioventus Incの経営陣

会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Anthony D'adamio, J.D.
Mr. Anthony D'adamio, J.D.
Senior Vice President, General Counsel
Senior Vice President, General Counsel
134.37K
+7.98%
Ms. Susan M. Stalnecker
Ms. Susan M. Stalnecker
Independent Director
Independent Director
105.96K
+33.34%
Mr. Guy Paul Nohra
Mr. Guy Paul Nohra
Independent Director
Independent Director
100.12K
--
Mr. Guido J. Neels
Mr. Guido J. Neels
Independent Director
Independent Director
85.24K
+45.10%
Mr. John A. Bartholdson
Mr. John A. Bartholdson
Independent Director
Independent Director
79.62K
+74.79%
Mr. Patrick J. (Pat) Beyer
Mr. Patrick J. (Pat) Beyer
Independent Director
Independent Director
76.44K
+53.05%
Ms. Michelle Mcmurry-Heath, M.D., Ph.D.
Ms. Michelle Mcmurry-Heath, M.D., Ph.D.
Independent Director
Independent Director
57.00K
-23.70%
Mr. Philip G. Cowdy
Mr. Philip G. Cowdy
Independent Director
Independent Director
11.70K
--
Mr. Mark Singleton
Mr. Mark Singleton
Chief Financial Officer, Senior Vice President
Chief Financial Officer, Senior Vice President
--
--
Ms. Katrina Church, J.D.
Ms. Katrina Church, J.D.
Senior Vice President, Chief Compliance Officer
Senior Vice President, Chief Compliance Officer
--
--
詳細を見る
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Anthony D'adamio, J.D.
Mr. Anthony D'adamio, J.D.
Senior Vice President, General Counsel
Senior Vice President, General Counsel
134.37K
+7.98%
Ms. Susan M. Stalnecker
Ms. Susan M. Stalnecker
Independent Director
Independent Director
105.96K
+33.34%
Mr. Guy Paul Nohra
Mr. Guy Paul Nohra
Independent Director
Independent Director
100.12K
--
Mr. Guido J. Neels
Mr. Guido J. Neels
Independent Director
Independent Director
85.24K
+45.10%
Mr. John A. Bartholdson
Mr. John A. Bartholdson
Independent Director
Independent Director
79.62K
+74.79%
Mr. Patrick J. (Pat) Beyer
Mr. Patrick J. (Pat) Beyer
Independent Director
Independent Director
76.44K
+53.05%

収益内訳

通貨: USD更新時刻: Mon, Oct 6
通貨: USD更新時刻: Mon, Oct 6
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
事業別USD
会社名
収益
比率
Pain Treatments and Joint Preservation
73.31M
49.65%
Surgical solutions
52.72M
35.70%
Restorative Therapies
21.64M
14.65%
地域別USD
会社名
収益
比率
United States
128.78M
87.21%
International
18.89M
12.79%
事業別
地域別
事業別USD
会社名
収益
比率
Pain Treatments and Joint Preservation
73.31M
49.65%
Surgical solutions
52.72M
35.70%
Restorative Therapies
21.64M
14.65%

株主

更新時刻: Mon, Nov 17
更新時刻: Mon, Nov 17
株主統計
種類
株主統計
株主統計
比率
EW Healthcare Partners
19.44%
Juniper Investment Company, LLC
10.36%
Smith & Nephew Group plc
9.30%
Nantahala Capital Management, LLC
8.68%
The Vanguard Group, Inc.
4.30%
他の
47.92%
株主統計
株主統計
比率
EW Healthcare Partners
19.44%
Juniper Investment Company, LLC
10.36%
Smith & Nephew Group plc
9.30%
Nantahala Capital Management, LLC
8.68%
The Vanguard Group, Inc.
4.30%
他の
47.92%
種類
株主統計
比率
Investment Advisor/Hedge Fund
22.94%
Venture Capital
19.55%
Investment Advisor
15.40%
Hedge Fund
14.00%
Corporation
9.30%
Individual Investor
2.50%
Research Firm
1.72%
Insurance Company
0.47%
Bank and Trust
0.20%
他の
13.93%

機関投資家保有株

更新時刻: Mon, Dec 8
更新時刻: Mon, Dec 8
報告期間
機関投資家数
保有株式数
比率
変動額
2025Q4
319
49.87M
91.76%
-1.55K
2025Q3
324
49.87M
92.42%
+451.64K
2025Q2
315
49.43M
88.24%
+1.39M
2025Q1
300
47.59M
85.68%
-9.15M
2024Q4
302
46.29M
87.45%
+580.76K
2024Q3
303
45.64M
84.02%
-1.26M
2024Q2
271
47.35M
78.83%
+4.38M
2024Q1
269
42.96M
79.86%
-7.88M
2023Q4
267
41.98M
81.20%
+236.50K
2023Q3
256
41.69M
80.71%
+844.38K
詳細を見る

株主動向

会社名
保有株式数
比率
変動額
変動率
日付
EW Healthcare Partners
13.02M
19.47%
--
--
Jun 30, 2025
Juniper Investment Company, LLC
6.94M
10.37%
--
--
Jun 30, 2025
Smith & Nephew Group plc
6.23M
9.31%
--
--
Apr 07, 2025
Nantahala Capital Management, LLC
5.28M
7.89%
+1.16M
+28.00%
Jun 30, 2025
The Vanguard Group, Inc.
2.77M
4.14%
+223.28K
+8.77%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
2.82M
4.21%
+259.59K
+10.15%
Jun 30, 2025
Royce Investment Partners
1.09M
1.63%
+199.86K
+22.40%
Jun 30, 2025
Geode Capital Management, L.L.C.
1.05M
1.58%
+122.14K
+13.09%
Jun 30, 2025
American Century Investment Management, Inc.
1.12M
1.68%
+79.83K
+7.64%
Jun 30, 2025
Kent Lake PR LLC
350.04K
0.52%
+350.04K
--
Jun 30, 2025
詳細を見る

関連ETF

更新時刻: Sat, Dec 6
更新時刻: Sat, Dec 6
銘柄名
比率
Vanguard US Multifactor ETF
0.1%
VictoryShares Small Cap Free Cash Flow ETF
0.1%
Harbor Human Capital Factor US Small Cap ETF
0.09%
Fidelity Enhanced Small Cap ETF
0.09%
iShares Micro-Cap ETF
0.06%
Principal U.S. Small-Cap ETF
0.05%
Vanguard US Value Factor ETF
0.04%
Humankind US Stock ETF
0.03%
WisdomTree US SmallCap Fund
0.03%
Avantis US Small Cap Value ETF
0.03%
詳細を見る
Vanguard US Multifactor ETF
比率0.1%
VictoryShares Small Cap Free Cash Flow ETF
比率0.1%
Harbor Human Capital Factor US Small Cap ETF
比率0.09%
Fidelity Enhanced Small Cap ETF
比率0.09%
iShares Micro-Cap ETF
比率0.06%
Principal U.S. Small-Cap ETF
比率0.05%
Vanguard US Value Factor ETF
比率0.04%
Humankind US Stock ETF
比率0.03%
WisdomTree US SmallCap Fund
比率0.03%
Avantis US Small Cap Value ETF
比率0.03%

配当金

過去5年間の配当金総支払額は 0.00 米ドルである。
日付
配当金
権利確定日
支払日
配当落ち日
データなし

株式分割

日付
種類
比率
データなし
日付
種類
比率
データなし

よくある質問

Bioventus Incの上位5名の株主は誰ですか?

Bioventus Incの上位5名の株主は以下のとおりです。
EW Healthcare Partnersは13.02M株を保有しており、これは全体の19.47%に相当します。
Juniper Investment Company, LLCは6.94M株を保有しており、これは全体の10.37%に相当します。
Smith & Nephew Group plcは6.23M株を保有しており、これは全体の9.31%に相当します。
Nantahala Capital Management, LLCは5.28M株を保有しており、これは全体の7.89%に相当します。
The Vanguard Group, Inc.は2.77M株を保有しており、これは全体の4.14%に相当します。

Bioventus Incの株主タイプ上位3種は何ですか?

Bioventus Incの株主タイプ上位3種は、
EW Healthcare Partners
Juniper Investment Company, LLC
Smith & Nephew Group plc

Bioventus Inc(BVS)の株式を保有している機関の数はいくつですか?

2025Q4時点で、Bioventus Incの株式を保有している機関は319社あり、保有株式の総市場価値は約49.87Mで、全体の91.76%を占めています。2025Q3と比較して、機関の持ち株は-0.66%増加しています。

Bioventus Incの最大の収益源は何ですか?

FY2025Q2において、Pain Treatments and Joint Preservation部門がBioventus Incにとって最大の収益を生み出しており、その金額は73.31Mで、全収益の49.65%を占めています。
KeyAI